Target intelligence / Profile preview

EF-hand domain-containing protein 1 (EFHC1)

Target
EFHC1
Molecular classification
Other (it is a cytoskeletal-associated protein containing EF-hand domains, not a receptor, enzyme, transporter, channel, or transcription factor)
01

Overview

EF-hand domain-containing protein 1 (EFHC1) is an evolutionarily conserved protein characterized by the presence of EF-hand calcium-binding motifs and is required for proper function of cilia—organelle structures protruding from cells involved in sensing and signaling[1][2]. EFHC1 localizes to motile and non-motile cilia as well as to presynaptic regions of neurons, where it is involved in regulating neuronal excitability, mechanosensory processing, and dopamine neurotransmission[1][2]. In humans, mutations in the EFHC1 gene represent one of the most frequent identifiable causes of juvenile myoclonic epilepsy, a common idiopathic epilepsy syndrome[1][2]. EFHC1 is not a receptor or classical drug target, but its pivotal role in ciliary signaling and synaptic function explains its importance in neurodevelopment and disease, particularly in epilepsy through altered neuronal signal thresholds and neurotransmitter regulation[1][2].

Other names
FLJ10466RIB72POC9Myoclonin-1EJM1dJ304B14.2
02

Mechanism of action

Not a direct drug target; mutations cause loss-of-function influencing cilia and neuronal signaling

03

Biological functions

Ciliary function and structure (motile and non-motile cilia)Regulation of neuronal excitabilityModulation of dopamine signalingMechanosensation in neurons
04

Disease associations

Neurodegenerative disease (implicated in epilepsy, specifically juvenile myoclonic epilepsy)Other (neurological dysfunction)
05

Safety considerations

Genetic mutations associated with risk of juvenile myoclonic epilepsyPotential broader effects from loss of function in neuronal cilia and synaptic signaling
06

Biomarkers

No recognized clinical biomarkers in routine use; mutations can serve as genetic markers for juvenile myoclonic epilepsy

Beyond the preview

Go deeper on EF-hand domain-containing protein 1 (EFHC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EF-hand domain-containing protein 1 (EFHC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call